נוגדנים הנקשרים ל–tl1a ושימושים בהם

• 收藏
• 分享

专利权人:

GLENMARK PHARMACEUTICALS S.A.

发明人:

申请号：

IL23963415

公开号：

IL239634A

申请日:

2015.06.25

申请国别(地区):

IL

年份:

2019

代理人:

摘要：

The present invention relates to antibodies or fragments thereof that bind to TL1A. More specifically, the present invention relates to an antibody or fragment thereof that binds to TL1A comprising a heavy chain CDR1 comprising the amino acid sequence of SEQ ID NO: 51, and/or a heavy chain CDR2 comprising the amino acid sequence of SEQ ID NO: 52, and/or a heavy chain CDR3 comprising the amino acid sequence of SEQ ID NO: 53； and/or comprising a light chain CDR1 comprising the amino acid sequence of SEQ ID NO: 54, and/or a light chain CDR2 comprising the amino acid sequence of SEQ ID NO: 55 and/or a light chain CDR3 comprising the amino acid sequence of SEQ ID NO: 56.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/